Company Filing History:
1 out of 66 
1 out of 48 
1 out of 15 Years Active: 2020-2024
Title: Katherine Scott: Innovator in Cannabinoid Research
Introduction
Katherine Scott is a prominent inventor based in London, GB. She has made significant contributions to the field of cannabinoid research, particularly in the treatment of leukemia. With a total of 3 patents to her name, her work is paving the way for innovative therapeutic approaches.
Latest Patents
Katherine's latest patents focus on the combination of cannabinoids in the treatment of leukemia. The present invention relates to the use of a combination of two different cannabinoids, specifically CBD and THC, which appears to be particularly effective in reducing cell numbers in this disease. The cannabinoids can be used in the form of an extract that co-extracts many naturally occurring compounds with THC or CBD. Alternatively, they may be present in a highly purified extract, where CBD or THC is present at greater than 98% of the total extract. A specific ratio of CBD and THC, such as 10:1 to 1:10 or more preferably between 2:1 to 1:2, may be utilized for optimal effectiveness.
Career Highlights
Katherine has worked with notable companies in the field, including GW Pharma Limited and GW Research Limited. Her experience in these organizations has contributed to her expertise and innovative research in cannabinoid applications.
Collaborations
Katherine has collaborated with esteemed colleagues such as Wai Liu and Angus Dalgleish, further enhancing her research and development efforts in cannabinoid therapies.
Conclusion
Katherine Scott's work in cannabinoid research represents a significant advancement in the treatment of leukemia. Her innovative patents and collaborations highlight her dedication to improving therapeutic options for patients.